714 related articles for article (PubMed ID: 30850590)
21. Precise and broad scope genome editing based on high-specificity Cas9 nickases.
Wang Q; Liu J; Janssen JM; Le Bouteiller M; Frock RL; Gonçalves MAFV
Nucleic Acids Res; 2021 Jan; 49(2):1173-1198. PubMed ID: 33398349
[TBL] [Abstract][Full Text] [Related]
22. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
24. Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells.
Prat F; Toutain J; Boutin J; Amintas S; Cullot G; Lalanne M; Lamrissi-Garcia I; Moranvillier I; Richard E; Blouin JM; Dabernat S; Moreau-Gaudry F; Bedel A
Stem Cell Reports; 2020 Sep; 15(3):677-693. PubMed ID: 32795423
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
26. Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.
Malinin NL; Lee G; Lazzarotto CR; Li Y; Zheng Z; Nguyen NT; Liebers M; Topkar VV; Iafrate AJ; Le LP; Aryee MJ; Joung JK; Tsai SQ
Nat Protoc; 2021 Dec; 16(12):5592-5615. PubMed ID: 34773119
[TBL] [Abstract][Full Text] [Related]
27. Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.
Lazzarotto CR; Nguyen NT; Tang X; Malagon-Lopez J; Guo JA; Aryee MJ; Joung JK; Tsai SQ
Nat Protoc; 2018 Nov; 13(11):2615-2642. PubMed ID: 30341435
[TBL] [Abstract][Full Text] [Related]
28. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
29. Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens.
Collonnier C; Guyon-Debast A; Maclot F; Mara K; Charlot F; Nogué F
Methods; 2017 May; 121-122():103-117. PubMed ID: 28478103
[TBL] [Abstract][Full Text] [Related]
30. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
[TBL] [Abstract][Full Text] [Related]
31. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
[TBL] [Abstract][Full Text] [Related]
32. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.
Paix A; Folkmann A; Seydoux G
Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263
[TBL] [Abstract][Full Text] [Related]
33. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9.
Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ
Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733
[TBL] [Abstract][Full Text] [Related]
34. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
[TBL] [Abstract][Full Text] [Related]
35. Generation of chromosomal translocations that lead to conditional fusion protein expression using CRISPR-Cas9 and homology-directed repair.
Vanoli F; Jasin M
Methods; 2017 May; 121-122():138-145. PubMed ID: 28522325
[TBL] [Abstract][Full Text] [Related]
36. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
37. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.
Chung CH; Allen AG; Sullivan NT; Atkins A; Nonnemacher MR; Wigdahl B; Dampier W
Mol Ther; 2020 Jan; 28(1):19-28. PubMed ID: 31672284
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
39. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
40. Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks.
Brinkman EK; Chen T; de Haas M; Holland HA; Akhtar W; van Steensel B
Mol Cell; 2018 Jun; 70(5):801-813.e6. PubMed ID: 29804829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
